Cargando…

A rare case of sarcoidosis-associated pulmonary hypertension in a patient exposed to silica

Mechanism of sarcoidosis-associated pulmonary hypertension may be challenging and requires high-quality imaging http://ow.ly/UvJPh

Detalles Bibliográficos
Autores principales:	Bourlier, Delphine, O'Connell, Caroline, Montani, David, Savale, Laurent, Seferian, Andrei, Parent, Florence, Humbert, Marc, Simonneau, Gérald, Sitbon, Olivier, Jaïs, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2016
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487671/ https://www.ncbi.nlm.nih.gov/pubmed/26929426 http://dx.doi.org/10.1183/16000617.0073-2015

Ejemplares similares

Pulmonary Hypertension Complicating Fibrosing Mediastinitis
por: Seferian, Andrei, et al.
Publicado: (2015)

Pulmonary hypertension associated with neurofibromatosis type 1
por: Jutant, Etienne-Marie, et al.
Publicado: (2018)

Acute decompensated pulmonary hypertension
por: Savale, Laurent, et al.
Publicado: (2017)

Sequential combination therapy with parenteral prostacyclin in BMPR2 mutations carriers
por: Boucly, Athénaïs, et al.
Publicado: (2022)

Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
por: Weatherald, Jason, et al.
Publicado: (2021)

French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
por: Brenot, Philippe, et al.
Publicado: (2019)

Reply to Jin et al. and to Sun et al.
por: Boucly, Athénaïs, et al.
Publicado: (2021)

Factors predicting outcome after pulmonary endarterectomy
por: Tromeur, Cécile, et al.
Publicado: (2018)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation
por: Montani, David, et al.
Publicado: (2021)

Pulmonary hypertension associated with busulfan
por: Hagenburg, Jean, et al.
Publicado: (2021)

Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission
por: Jevnikar, Mitja, et al.
Publicado: (2021)

Screening for pulmonary arterial hypertension in systemic sclerosis
por: Weatherald, Jason, et al.
Publicado: (2019)

External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry
por: Boucly, Athénaïs, et al.
Publicado: (2022)

Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation
por: Beurnier, Antoine, et al.
Publicado: (2020)

Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis
por: Launay, David, et al.
Publicado: (2018)

Chronic thromboembolic pulmonary hypertension complicating long-term cyproterone acetate therapy
por: Montani, David, et al.
Publicado: (2014)

Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension
por: Girerd, Barbara, et al.
Publicado: (2010)

An emerging phenotype of pulmonary arterial hypertension patients carrying SOX17 variants
por: Montani, David, et al.
Publicado: (2022)

Non-Invasive Determination of Cardiac Output in Pre-Capillary Pulmonary Hypertension
por: Lador, Frédéric, et al.
Publicado: (2015)

Respiratory symptoms and radiological findings in post-acute COVID-19 syndrome
por: Jutant, Etienne-Marie, et al.
Publicado: (2022)

Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?
por: Huertas, Alice, et al.
Publicado: (2020)

Functional respiratory complaints among COVID-19 survivors: a prospective cohort study
por: Beurnier, Antoine, et al.
Publicado: (2023)

Sex and gender in pulmonary arterial hypertension
por: Cheron, Céline, et al.
Publicado: (2021)

Lung Ventilation/Perfusion Scintigraphy for the Screening of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Which Criteria to Use?
por: Le Pennec, Romain, et al.
Publicado: (2022)

The isobaric pulmonary arterial compliance in pulmonary hypertension
por: Chemla, Denis, et al.
Publicado: (2021)

Reply to Jha
por: Montani, David, et al.
Publicado: (2022)

COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study
por: Montani, David, et al.
Publicado: (2022)

Symptômes respiratoires et anomalies radiologiques dans le COVID long
por: Jutant, E.M., et al.
Publicado: (2022)

Multidisciplinary approach for post-acute COVID-19 syndrome: time to break down the walls
por: Montani, David, et al.
Publicado: (2021)

Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era
por: Launay, David, et al.
Publicado: (2013)

Pathogenesis of pulmonary arterial hypertension: lessons from cancer
por: Guignabert, Christophe, et al.
Publicado: (2013)

WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension
por: Savale, Laurent, et al.
Publicado: (2022)

N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats
por: Chaumais, Marie-Camille, et al.
Publicado: (2014)

Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era
por: Savale, Laurent, et al.
Publicado: (2018)

Rapid onset honeycombing fibrosis in spontaneously breathing patient with COVID-19
por: Combet, Margot, et al.
Publicado: (2020)

Silica dust and sarcoidosis in Swedish construction workers
por: Jonsson, E, et al.
Publicado: (2019)

Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study
por: Rhodes, Christopher J, et al.
Publicado: (2017)

Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension
por: Sitbon, Olivier, et al.
Publicado: (2020)

Hypoxemia during sleep and overnight rostral fluid shift in pulmonary arterial hypertension: a pilot study
por: Jutant, Etienne-Marie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ukapejbj4k21n49eolt4u796e1